These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 570737)

  • 1. Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta.
    Hatton MW; Berry LR; Regoeczi E
    Thromb Res; 1978 Oct; 13(4):655-70. PubMed ID: 570737
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wall.
    Dryjski M; Larsson R; Olsson P; Swedenborg J
    Thromb Res; 1983 Nov; 32(4):355-63. PubMed ID: 6658719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III modulates the effect of thrombin on the metabolism of glycosaminoglycans in cultured endothelial cells.
    Akai T; Kaji T; Hayakawa Y; Hayashi T; Sakuragawa N
    Thromb Res; 1991 Jun; 62(6):707-16. PubMed ID: 1926061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin inhibition by antithrombin III on the subendothelium is explained by the isoform AT beta.
    Frebelius S; Isaksson S; Swedenborg J
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1292-7. PubMed ID: 8857927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of esterase and amidase activities of alpha- and beta-thrombin in the presence of antithrombin III and heparin.
    Borsodi A; Machovich R
    Biochim Biophys Acta; 1979 Feb; 566(2):385-9. PubMed ID: 570423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: importance of heparin cofactor II.
    Buchanan MR; Liao P; Smith LJ; Ofosu FA
    Thromb Res; 1994 Jun; 74(5):463-75. PubMed ID: 8085247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II].
    Zhang G
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalysis of thrombin inhibition provides an index for estimating the antithrombotic potential of glycosaminoglycans in rabbits.
    Fernandez FA; Buchanan MR; Hirsh J; Fenton JW; Ofosu FA
    Thromb Haemost; 1987 Jun; 57(3):286-93. PubMed ID: 3116701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulations of thrombin activity by polyelectrolytes in the presence of antithrombin III.
    Schiele J; Heuck CC
    Semin Thromb Hemost; 1991; 17 Suppl 1():35-41. PubMed ID: 2068569
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of thrombin by antithrombin III on a heparinized biomaterial.
    Goosen MF; Sefton MV; Hatton MW
    Thromb Res; 1980 Dec 1-15; 20(5-6):543-54. PubMed ID: 7233384
    [No Abstract]   [Full Text] [Related]  

  • 13. A role for pericellular proteoglycan in the binding of thrombin or antithrombin III by the blood vessel endothelium? The effects of proteoglycan-degrading enzymes and glycosaminoglycan-binding proteins on 125I-thrombin binding by the rabbit thoracic aorta in vitro.
    Hatton MW; Moar SL
    Thromb Haemost; 1985 Apr; 53(2):228-34. PubMed ID: 4024034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB; Edward M; Winter JH; Bennett NB
    Thromb Res; 1980 Feb 1-15; 17(3-4):539-44. PubMed ID: 6768163
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two distinct heparin cofactors in human plasma. II. Inhibition of thrombin and activated factor X.
    Briginshaw GF; Shanberge JN
    Thromb Res; 1974 Mar; 4(3):463-77. PubMed ID: 4857333
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of thrombin on subendothelium. Studies on rabbit aorta, ex vivo.
    Nydahl S; Frebelius S; Swedenborg J
    Eur Surg Res; 1989; 21(5):287-95. PubMed ID: 2627983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of thrombin by antithrombin III in the presence of cultured human fibroblasts.
    Brandt JT; Stephens RE; Hinkle GH
    Thromb Res; 1988 Jul; 51(2):187-96. PubMed ID: 2973155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.